Liberty One Investment Management LLC increased its holdings in The Clorox Company (NYSE:CLX – Free Report) by 11.5% during the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 224,873 shares of the company’s stock after purchasing an additional 23,132 shares during the quarter. Clorox accounts for 2.7% of Liberty One Investment Management LLC’s investment portfolio, making the stock its 14th biggest position. Liberty One Investment Management LLC owned 0.18% of Clorox worth $27,000,000 as of its most recent SEC filing.
A number of other large investors also recently added to or reduced their stakes in the business. Triton Financial Group Inc purchased a new position in Clorox in the 2nd quarter worth $869,000. Journey Advisory Group LLC raised its position in Clorox by 22.1% in the 2nd quarter. Journey Advisory Group LLC now owns 1,991 shares of the company’s stock worth $239,000 after purchasing an additional 360 shares during the period. Bogart Wealth LLC raised its position in Clorox by 289.5% in the 2nd quarter. Bogart Wealth LLC now owns 370 shares of the company’s stock worth $44,000 after purchasing an additional 275 shares during the period. Canvas Wealth Advisors LLC raised its position in Clorox by 190.5% in the 2nd quarter. Canvas Wealth Advisors LLC now owns 29,548 shares of the company’s stock worth $3,760,000 after purchasing an additional 19,377 shares during the period. Finally, Stephens Inc. AR raised its position in Clorox by 32.4% in the 2nd quarter. Stephens Inc. AR now owns 3,778 shares of the company’s stock worth $454,000 after purchasing an additional 924 shares during the period. Hedge funds and other institutional investors own 78.53% of the company’s stock.
Analyst Upgrades and Downgrades
A number of equities analysts have issued reports on CLX shares. Citigroup decreased their price objective on shares of Clorox from $135.00 to $130.00 and set a “neutral” rating on the stock in a research report on Wednesday, October 8th. Barclays decreased their price objective on shares of Clorox from $118.00 to $112.00 and set an “underweight” rating on the stock in a research report on Tuesday, September 30th. JPMorgan Chase & Co. decreased their price objective on shares of Clorox from $135.00 to $127.00 and set a “neutral” rating on the stock in a research report on Friday, October 10th. Zacks Research upgraded shares of Clorox from a “strong sell” rating to a “hold” rating in a research report on Monday, September 29th. Finally, The Goldman Sachs Group decreased their price objective on shares of Clorox from $115.00 to $110.00 and set a “sell” rating on the stock in a research report on Wednesday, October 1st. One research analyst has rated the stock with a Buy rating, twelve have assigned a Hold rating and four have assigned a Sell rating to the stock. Based on data from MarketBeat.com, Clorox currently has an average rating of “Reduce” and an average price target of $130.20.
Clorox Price Performance
Shares of NYSE CLX opened at $119.60 on Tuesday. The Clorox Company has a 1 year low of $116.53 and a 1 year high of $171.37. The company has a debt-to-equity ratio of 5.15, a current ratio of 0.84 and a quick ratio of 0.57. The company’s 50-day moving average is $121.56 and its 200 day moving average is $127.42. The stock has a market capitalization of $14.56 billion, a P/E ratio of 18.34, a P/E/G ratio of 0.99 and a beta of 0.52.
Clorox (NYSE:CLX – Get Free Report) last announced its quarterly earnings results on Thursday, July 31st. The company reported $2.87 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.24 by $0.63. Clorox had a net margin of 11.40% and a return on equity of 377.86%. The company had revenue of $1.99 billion for the quarter, compared to analysts’ expectations of $1.94 billion. During the same quarter in the previous year, the company earned $1.82 earnings per share. Clorox’s quarterly revenue was up 4.5% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. On average, sell-side analysts expect that The Clorox Company will post 7.15 earnings per share for the current year.
Clorox Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, November 6th. Shareholders of record on Wednesday, October 22nd will be issued a $1.24 dividend. This represents a $4.96 dividend on an annualized basis and a yield of 4.1%. The ex-dividend date is Wednesday, October 22nd. Clorox’s dividend payout ratio is 76.07%.
Insiders Place Their Bets
In other Clorox news, COO Eric H. Reynolds sold 15,041 shares of the company’s stock in a transaction dated Thursday, September 4th. The shares were sold at an average price of $123.78, for a total value of $1,861,774.98. Following the sale, the chief operating officer owned 54,221 shares in the company, valued at approximately $6,711,475.38. This represents a 21.72% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Company insiders own 0.63% of the company’s stock.
Clorox Company Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Further Reading
- Five stocks we like better than Clorox
- What is a buyback in stocks? A comprehensive guide for investors
- Louis Vuitton Earnings Show Luxury Bull Market Isn’t Done Yet
- 3 Warren Buffett Stocks to Buy Now
- 3 High-Yield Banks for Investors to Buy on the Dip
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- 5 Surprising Stocks Set to Benefit From a Future Robotics Boom
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.